Excellis
VC Fund
Turin, Italy
Excellis is a private investment company focusing on Robotics Automation.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Excellis invests in
Stages Excellis invests in
Countries Excellis invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.3M–$10M
- Series A
- $5.8M–$14M
Investment Focus
Industry
- Health Care 3 (27%)
- Internet of Things 3 (27%)
- Medical 2 (18%)
- Life Science 2 (18%)
- Semiconductor 2 (18%)
Stage
- Seed 5 (45%)
- Series A 3 (27%)
- Series B 1 (9%)
- Funding Round 1 (9%)
Country
- Switzerland 7 (64%)
- United Kingdom 3 (27%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alberto Emprin
Chairman
|
Chairman | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Helix Robotics is developing the first commercial soft robot manipulator, addressing the need for human-friendly and reliable robotics. | $5M / Seed / Sep 16, 2026 | ||
| Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance (“µNMR”) at a scale 10-fold better than existing technologies. | Seed / Apr 29, 2025 | ||
| MintNeuro is pioneering the use of semiconductor technology in next-generation neural implants. | $1.3M / Seed / Nov 12, 2024 | ||
| FluoRok is revolutionizing the way fluorochemicals are produced globally. | $10.3M / Seed / Sep 23, 2024 | ||
| Synthara is a Zurich-based artificial intelligence (AI) company that provides system-level solutions for businesses to enhance their products or services with smart features. The company portable and wearable gadgets such as virtual reality headsets, small wireless monitoring cameras, sensor networks, have limited smart features because computingpowerful algorithms cannot be run on them. Synthara IPs provide server-class performance with an extremely low energy requirement for neural networks (10 TOPs/Watt). | $11M / Jun 05, 2024 | ||
| Synthara is a Swiss semiconductor startup revolutionizing the compute performance of embedded chips by orders of magnitude. We are working on a new breed of energy-efficient computational AI chips that are hand-crafted for smart sensor applications such as hearing aids, wearables, biomedical monitoring, and AR/VR. Our flagship product,ComputeRAM, is a drop-in replacement for conventional SRAM that performs complex calculations directly in memory. This drastically reduces CPU workload, boosting system performance and delivering exceptional efficiency, especially for AI workloads. With ComputeRAM, we help chipmakers and device manufacturers lower costs, shorten time to market, and unlock new opportunities for innovation. | $5.5M / Seed / Jun 05, 2024 | ||
| Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested today, by introducing the first “Organism-on-Chip” technology. | $14.5M / Series A / Sep 28, 2023 | ||
| Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices. The company was founded in 2014 and is headquartered in Zurich, Switzerland. | $5.1M / Series B / Sep 05, 2023 | ||
| Zaphiro has developed a real-time monitoring and automation system that enhances the efficiency and profitability of grid operations. Moreover, Zaphiro Technologies transforms the electrical distribution grids from passive to pro-active.Zaphiro Technologies is a spin-off of the Swiss Federal Institute of Technology of Lausanne (EPFL). It has beenincorporated in April 2017 and co-founded by 3 researchers: Paolo Romano, Marco Pignati and Lorenzo Zanni. | $6.9M / Series A / Dec 19, 2022 | ||
| TOffeeAM optimizes product designs for 3D printing. TOffeeAM creates structures within smart industrial production, such as coolant systems for gas turbines exceeding the performance of current heat exchangers. | $5.8M / Series A / Nov 08, 2022 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Excellis invest in?
Excellis invests primarily in Health Care, Internet of Things and Medical startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Excellis invest in?
Excellis typically joins rounds of $1.3M–$10M at Seed and $5.8M–$14M at Series A. These are whole funding-round sizes, not Excellis's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Excellis took part in.
How do I contact Excellis?
Public channels for Excellis include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Excellis?
The team at Excellis includes Alberto Emprin (Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
